Nitrofurantoin (Macrobid) for Uncomplicated Cystitis
For adults with normal renal function and uncomplicated cystitis, prescribe nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days. This represents the optimal first-line choice based on high efficacy (93% clinical cure rate), minimal resistance, and low collateral damage to normal flora 1.
Dosing Regimen
Standard dosing: 100 mg twice daily for 5 days 1, 2
- Take with food to increase bioavailability by approximately 40% 3
- The FDA label indicates 7 days of therapy 3, but current guidelines support 5 days as equally effective with better tolerability 1, 4
Evidence Supporting 5-Day Regimen
The Gupta 2007 trial demonstrated that 5 days of nitrofurantoin (100 mg twice daily) achieved equivalent outcomes to 3 days of trimethoprim-sulfamethoxazole, with 90% early clinical cure and 84% late clinical cure at 30 days 4. This shorter duration minimizes adverse effects while maintaining efficacy comparable to 7-day regimens (88-93% clinical cure rates) 1.
Critical Contraindications
Renal Function Requirements
Absolute contraindication: CrCl <30 mL/min 3
Controversial zone (CrCl 30-60 mL/min): The FDA label lists CrCl <60 mL/min as a contraindication 3, but this recommendation lacks robust clinical evidence 5. Recent data suggest:
- CrCl 40-60 mL/min: Nitrofurantoin may be used cautiously, though efficacy decreases with declining renal function 6, 5, 7
- For every 10 mL/min decrease in eGFR, clinical failure risk increases by 5% (aOR 1.05) 6
- Below 40 mL/min: Consider fosfomycin or other alternatives, as urinary concentrations become inadequate 5
Other Absolute Contraindications
- Pregnancy: Last trimester (risk of hemolytic anemia in newborn) 3
- Pyelonephritis or perinephric abscess: Nitrofurantoin does not achieve therapeutic tissue concentrations 3, 8
- Suspected bacteremia: Inadequate serum levels 8
Clinical Efficacy Profile
Nitrofurantoin demonstrates:
- Clinical cure: 88-93% 1
- Microbiological cure: 86-92% 1
- Comparable efficacy to ciprofloxacin, trimethoprim-sulfamethoxazole, and superior to fosfomycin for microbiological cure (86% vs 78%, p=0.02) 1
Why Nitrofurantoin is First-Line
- Minimal resistance: Maintains activity despite 60+ years of use due to multiple mechanisms of action 9, 10
- Low collateral damage: High urinary concentration with minimal serum/tissue levels preserves gut and vaginal flora 1, 9
- Fluoroquinolone-sparing: Reserves broader-spectrum agents for more serious infections 1
Common Pitfalls to Avoid
Do NOT Use Nitrofurantoin For:
- Pyelonephritis: Inadequate tissue penetration 3
- Complicated UTI with systemic symptoms: Risk of bacteremia 8
- Men with suspected prostatitis: Poor prostatic penetration 8
- Severe renal impairment (CrCl <30-40 mL/min): Inadequate urinary concentrations 6, 5
Adverse Effects to Monitor
Common (5-34%): Nausea, headache 1
Serious but rare (primarily with long-term use):
Risk mitigation: These serious effects occur predominantly with prolonged therapy (>6 months), not with short 5-day courses 11, 10. The 50 mg daily prophylaxis dose shows lower adverse event rates than 100 mg for long-term use 12.
Alternative Agents When Nitrofurantoin Cannot Be Used
Second-line options (in order of preference when nitrofurantoin contraindicated):
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days—only if local resistance <20% 1
- Fosfomycin trometamol 3 g single dose—inferior microbiological cure but acceptable alternative 1, 13
- Fluoroquinolones (ciprofloxacin, levofloxacin) 3 days—reserve for important indications due to collateral damage 1
Special Populations
Males: Limited data, but recent evidence suggests comparable efficacy to females (86.5% overall cure rate) 7. However, must exclude prostatitis before prescribing.
Postmenopausal women: Can use standard dosing, though technically outside "uncomplicated" UTI definition in some guidelines 1.
Pregnancy: Safe in first two trimesters; avoid in third trimester 11, 8.